Contact Us
Page Content
Leadership & Staff:
| Name & Title |
Biography |
Contact Info |
|---|
Daniel L. Gustafson, PhD
Director |
Dr. Gustafson is responsible for policies, procedures, personnel, budget, equipment, reports and Cancer Center meetings. He has directed Pharmacology since its inception and plays a role in study planning, method development, analysis and modeling of data.
Since Dr. Gustafson is the major expert in PK/PD modeling and analysis, he is an author on many of the publications as he spends his research time as well as his core time on these studies. He serves as management for GLP studies and maintains training records for GLP compliance |
daniel.gustafson@colostate.edu
970-297-1278 |
Ryan J. Hansen, PhD
Associate Director for Drug Analysis |
Dr. Hansen is responsible for quality control within Pharmacology as well as assisting in assay development and sample analysis. He has been associated with the Shared Resource since 2006 and has become experienced in LC/MS/MS analysis through on the job training by Dr. Gustafson and Dr. Joseph Zirrolli as well as through on-site training by Applied Biosystems (Christopher Borton, ABI Field Application Specialist). He is trained in GLP-compliance and serves as the compliance officer in GLP-compliant studies.. |
ryan.hansen@colostate.edu
970-297-4057 |
Erica L. Bradshaw Pierce, PhD
Associate Director PK/PD Modeling |
Dr. Pierce is responsible for modeling and simulation activities and is involved in PK, PK-PD and in vivo pharmacology study design. She has extensive academic and industry experience in: pharmacokinetic modeling and simulation; PK-PD study design and PK-PD modeling and simulation; physiologically-based pharmacokinetic (PBPK) modeling; drug combination strategies in oncology; application of absorption, distribution, metabolism and excretion (ADME) science to all phases of drug development; and development and utilization of oncology animal models. |
erica.pierce@ucdenver.edu
303-724-6577 |
Paul J. Lunghofer, MS
Sample Analyst |
Paul has worked in Pharmacology since 2009 and has become experienced in LC/MS/MS analysis through on the job training by Dr. Gustafson and Dr. Hansen. Currently, he is responsible for a majority of sample preparation and analysis as well as method development and validation. Mr. Lunghofer is trained in GLP-compliance and serves as an analyst in GLP-compliant studies. |
paul.lunghofer@colostate.edu
970-297-4079 |